and secretion of cytokines on activation and increased expression of the adhesion molecule L-selectin. A common CD risk allele, identified in GWAS, correlated with reduced expression of PRDM1 in ileal biopsy specimens and peripheral blood mononuclear cells (combined P ¼ 1.6 Â 10 À8 ). We identified an association between CD and a common missense variant, Val248Ala, in nuclear domain 10 protein 52 (NDP52) (P ¼ 4.83 Â 10 À9 ).
We found that this variant impairs the regulatory functions of NDP52 to inhibit nuclear factor kB activation of genes that regulate inflammation and affect the stability of proteins in Toll-like receptor pathways. CONCLUSIONS: We have extended the results of GWAS and provide evidence that variants in PRDM1 and NDP52 determine susceptibility to CD. PRDM1 maps adjacent to a CD interval identified in GWAS and encodes a transcription factor expressed by T and B cells. NDP52 is an adaptor protein that functions in selective autophagy of intracellular bacteria and signaling molecules, supporting the role of autophagy in the pathogenesis of CD.
Keywords: Inflammatory Bowel Disease; Whole-Exome Sequencing; Complex Disease. C rohn's disease (CD; MIM 266600) is characterized by relapsing/remitting intestinal inflammation and results from a complex interaction of host genetic factors and environmental stimuli in the mucosal immune compartment. Meta-analyses of genome-wide association studies (GWAS) have established a total of 140 CD susceptibility loci, [1] [2] [3] but these account for less than 14% of the total disease variance. Most appear to exert their effect by influencing the regulation of gene transcription rather than disrupting the coding sequence. A variety of approaches have been proposed to aid resolution of GWAS signals, and the need for functional interrogation is self-evident to further mechanistic understanding. However, for most GWAS loci, the causal variants remain unknown and the genes affected by these variants are yet to be identified.
The low proportion of overall heritability accounted for by GWAS studies has been a universal finding across common, complex disease. 4 A variety of explanations have been proposed, including overestimation of disease heritability, epigenetic effects, and a major contribution within families of low-frequency and rare variants. The extent to which the latter contributes may now be amenable to direct study. Whole-exome sequencing has become state of the art for detecting rare coding variants in Mendelian disorders, 5 but the utility of this approach in dissecting the contribution of rare and low-frequency coding variants to complex phenotypes is largely unknown. To further address this question, we generated exome sequence data from 42 unrelated subjects with CD and then used a single nucleotide variant (SNV) filtering strategy that incorporated association results from a recent CD meta-analysis data set 2 in combination with in silico mutation effect prediction algorithms (SNVs comprise single nucleotide polymorphisms [SNPs] and variants with <1% allele frequency in the general population). We performed follow-up genotyping in 8 independent case-control sets comprising 9348 subjects with CD, 2868 subjects with ulcerative colitis (UC), and 14,567 healthy control subjects of European ancestry. Using this approach, we identified and replicated novel causative low-frequency and rare missense variants associated with CD and/or UC and investigated their functional impact.
Subjects and Methods

Study Subjects
We captured the exomes of 42 German patients with CD, one HapMap trio, 6 and 3 unrelated German healthy control subjects by means of the NimbleGen 2.1M Human Exome Array (Madison, WI), followed by Illumina Genome Analyzer (San Diego, CA) resequencing (Supplementary Figures 1 and 2 and  Supplementary Table 1 ). For detailed information on the wholeexome enrichment and sequencing process and sequence read alignment, variant calling, and annotation, see Supplementary Notes. Follow-up genotyping of 9348 subjects with CD, 2868 subjects with UC, and 14,567 healthy control subjects was performed using Sequenom iPlex and TaqMan technology (Applied Biosystems Foster City, CA). For detailed information on quality control and association testing and on study subjects, see Supplementary Notes.
Expression Quantitative Trait Locus Analysis
We studied the correlation between PRDM1 expression and rs7746082 genotype in healthy control subjects on the basis of data from (1) ileal biopsies, (2) peripheral blood mononuclear cells (PBMCs), (3) CD4 þ
CD45RO
þ T cells, and
Ileal biopsy specimens were obtained from healthy study subjects undergoing colonoscopy for non--inflammatory bowel disease (IBD) indications (polyp surveillance and investigation of anemia). For the expression quantitative trait locus (eQTL) analysis in peripheral blood subsets, we recruited 42 volunteers from the Cambridge BioResource, 21 homozygous for each of the rs7746082 risk (C) and wild-type (WT) (G) alleles. PBMCs were isolated, and from these CD4 þ CD45RO À and CD4 þ CD45RO þ T cells were separated.
We focused on CD4 þ cells because prior evidence predominantly implicated this cell type in the pathogenesis of IBD. 7 We extracted and reverse transcribed messenger RNA and performed quantitative reverse-transcription polymerase chain reaction (qRT-PCR) using the 7500 Fast Real-Time PCR System (Applied Biosystems). Expression analysis was performed blinded to the genotype status. For detailed information on protocols, see Supplementary Notes.
In each of the 4 analyses, we computed the standardized mean differential expression T between individuals homozygous for the CD risk-associated rs7746082 allele "C" and individuals homozygous for the WT allele "G. 
Results
Discovery of Low-Frequency Variants Using Whole-Exome Sequencing
In total, we identified 117,957 SNVs in our 48 subjects with CD, including 59,076 coding and splice site SNVs (Supplementary Tables 2 and 3 ). The overall SNV analysis workflow of our study is shown in Supplementary Figure 3 .
To pinpoint a small subset of functionally important SNVs from the large amount of genetic variation, we developed a software tool for SNV annotation, categorization, and filtering named snpActs (Supplementary Table 4 and Supplementary Notes). Table 8 ).
Results of Association Testing
The missense SNP rs2303015 (Val248Ala) in the novel CD candidate gene NDP52 (MIM 604587; also known as CALCOCO2) was associated with CD (P ¼ 3.27 Â 10
À6
) with an odds ratio of 1.24 (95% confidence interval, 1.13-1.36) in panel C (Table 1 and Supplementary  Table 5 ). In the combined analysis of panels C and D, SNP rs2303015 attained classic genome-wide significance for CD (P ¼ 4.83 Â 10
À9
). We observed no association with UC at the NDP52 locus.
Results of eQTL Analysis
A locus on chromosome 6q21 adjacent to PRDM1 has been associated with CD in 3 GWAS meta-analyses. [1] [2] [3] To explore possible eQTL effects relating to this locus, we directly interrogated correlation between PRDM1 expression and genotype at rs7746082, the common lead SNP identified by the first CD GWAS meta-analysis.
1 SNP rs7746082 maps to a gene desert and PRDM1 represents one of only 2 genes within 500 kilobases; the other is ATG5 (MIM 604261). Both are strong positional candidate genes for IBD; PRDM1 (maps 100 kilobases downstream of rs7746082) encodes a master transcriptional regulator in B and T cells. ATG5 (197 kilobases downstream) encodes a critical component of autophagy, a pathway required for cellular innate immunity, which has previously been strongly implicated in the pathogenesis of CD. [8] [9] [10] [11] [12] Ileal biopsy specimens from the 13 individuals homozygous for the CD risk-associated "C" allele showed significantly lower expression of PRDM1 when compared with the 39 individuals homozygous for the WT allele "G"
; Figure 1A ). No such eQTL effect was observed for ATG5. Using immunohistochemistry, we observed PRDM1 to be expressed predominantly in mucosal T cells and plasma cells and not epithelial cells (Supplementary Figure 4) .
Given potential confounding by the mixed cell populations present in ileal mucosal biopsy specimens, we additionally studied this eQTL effect in peripheral blood subsets from an independent panel of healthy volunteers. Using qRT-PCR, we observed the same direction of eQTL effect as seen in ileal biopsy specimens in both PBMCs and CD4
þ T cells, with significantly lower expression in CC versus GG homozygotes (P ¼ .0006 and P ¼ .0125 for respective cell populations [ Figure 1B ]; combined P with ileal data ¼ 1.6 Â 10
À8
). The CD4 þ CD45RO
À subpopulation showed much lower PRDM1 expression and no eQTL effect. No eQTL effect was seen for ATG5 expression in the PBMCs or subsets.
Functional Characterization of Rare PRDM1 Variants
To investigate whether the rare PRDM1 variants we identified alter the phenotype and function of PBLs, we studied PBL subsets in patients with CD with and without PRDM1 variants chr6:106659789 (Ser354Asn) and chr6:10666076 (Leu450Phe). In accordance with murine studies on B cell-specific Prdm1 deletion, 13 patients with CD heterozygous for Ser354Asn and Leu450Phe exhibited significantly decreased levels of plasma cells and a nonsignificant trend toward reduction in memory and overall B-cell levels ( Figure 2A ). In contrast, absolute and relative numbers of CD4 þ , CD8 þ , and double-negative T cells and baseline expression levels of activation markers CD69, CD44, and CD25 were similar in all groups of subjects with CD (Supplementary Figure 5A-C and data not shown). However, while numbers of naive, central memory, and effector memory populations did not differ depending on the PRDM1 genotype (Supplementary Figure 5D and E), patients with CD heterozygous for the risk allele "A" of Ser354Asn but not the protective allele "T" of Leu450Phe exhibited increased expression of L-selectin (CD62L), an adhesion molecule critical for migration of PBLs into mesenteric lymph nodes, Peyer's NOTE. The first 6 SNVs for both CD and UC are low-frequency variants identified by the heuristic SNV filtering strategy that used whole-exome sequence data. For case/control allele frequencies in the individual genotyping panels, see Supplementary Table 7 . Additionally genotyped SNP markers listed represent best common association signals that were found previously in independent GWAS meta-analyses on CD and UC. 1, 2, 32 Marker rs7746082 represents the best association signal at 6q21 (PRDM1) in the scan of the first GWAS meta-analysis on CD. 1 rs6568421 represents the most significant associated SNP at 6q21 (PRDM1) in the scan of the second GWAS meta-analysis on CD.
2 rs6911490 is the best association signal at 6q21 (PRDM1) from the scan of the GWAS meta-analysis on UC. 32 Markers, which remained significant after Bonferroni correction, are shown in bold. At locus 6q21 (PRDM1), we observed significant associations of rare missense variants with CD (SNP chr6:106659789) and UC (SNP chr6:106660076). At 17p12 (NDP52), a highly significant association of the missense SNP rs230315 with CD but not UC was observed. The variants chr6:106659789A>G and chr106660076T>C correspond to Ser354Asn (CD-risk) and Leu450Phe (UC-protection), respectively. See Supplementary Table 5C, 5D, and 5F for additional information. SNV, SNP rs-id (if available from dbSNP130) or chromosome and position (NCBI build 36 coordinates) of marker; locus, the affected gene; A1, minor allele; A2, major allele; A1 Obs. , number of minor alleles observed in stage 1 and 2 genotyping; alleles Total , number of overall alleles in stage 1 and 2 genotyping; A1 freq.cases , average allele frequency of minor allele in cases in stage 1 and 2 genotyping; A1 freq.controls , average allele frequency of minor allele in controls in stage 1 and 2 genotyping; P, P value from permutation association testing (mega-analysis of rare variants); OR (95% CI), Cochran-Mantel-Haenszel odds ratio and 95% confidence interval with respect to minor allele A1; P combined , combined analysis P value of the European panel (panel C, Supplementary patches, and the lamina propria ( Figure 2B ). [14] [15] [16] In addition, despite similar baseline characteristics in expression of activation markers, both CD4 þ and CD8 þ T cells obtained from patients with CD heterozygous for the risk allele Ser354Asn but not the protective allele of Leu450-Phe exhibited dramatically increased proliferation, interferon (IFN)-g secretion, and up-regulation of activation markers upon stimulation, even under conditions of minimal T-cell receptor engagement (Figure 2C -E; flow cytometry histograms for Figure 2E are displayed in Supplementary Figure 6 ). To investigate whether ectopic expression of the risk allele Ser354Asn in T cells from healthy donors is associated with increased activation and cytokine secretion, we transduced PBLs from healthy controls expressing WT PRDM1 with lentiviruses expressing WT, Ser354Asn, and Leu450Phe PRDM1. In accordance with data obtained in patients with CD, T cells from healthy controls expressing Ser354Asn but not Leu450Phe exhibited increased proliferation, IFN-g secretion, and upregulation of activation markers upon stimulation ( Figure 3A and B and Supplementary Figure 5F ). Transduction rates were similar in all conditions ( Figure 3C ). Thus, PRDM1 Ser354Asn is associated with increased activation, cytokine secretion, and proliferation of CD4 þ and CD8 þ T cells.
Functional Assessment of Allelic Variants of NDP52
It has recently been shown that NDP52 negatively regulates Toll-like receptor (TLR)-triggered NF-kB activation. 17 We therefore analyzed the impact of the 2 allelic variants 248Val (WT) and 248Ala (risk) on NF-kB activation using the specific TLR stimulus poly(I:C), which is affected by NDP52 regulatory activity. As expected, the 248Val WT variant decreased NF-kB activation in response to poly(I:C) treatment. However, the 248Ala risk variant failed to decrease NF-kB activation ( Figure 4A ). We further confirmed the impaired capacity of the risk allele to dampen proinflammatory signaling by assessing nuclear localization of NF-kB subunit p65 after poly(I:C) treatment ( Figure 4B ). It is estimated that the suppressive function of NDP52 for proinflammatory signaling is mediated by ubiquitination events and a complex interplay between the proteasomal and the autophagic degradation systems. 17 We therefore analyzed structural features of the respective coiled coil region surrounding amino acid 248. As 
CD45RO
þ T-cell populations from an independent panel of control subjects showed a significant difference in PRDM1 expression between CC and GG genotypes at rs7746082 (P ¼ .0006 and P ¼ .0125, respectively). PRDM1 was expressed at lower levels in the CD4 þ
À population and did not correlate with genotype at rs7746082 (P ¼ .449). CC, homozygous CD risk genotype at rs7746082; GG, homozygous WT genotype at rs7746082. depicted in Figure 4C , this structure prediction analysis of the allelic variants indicates a possible role of the affected amino acid position 248 for binding of ubiquitin chains. Because NDP52 itself is supposed to be posttranslationally modified and subject to selective degradation in the course of TLR activation, 17 we next characterized the stability of NDP52 protein complexes under poly(I:C)-triggered TLRactivating conditions. As shown in Figure 4D , TLR activation resulted in time-dependent degradation of NDP52 of the 248Val WT allele. Intriguingly, this effect was impaired for the 248Ala risk variant, as documented by the increased stability of the NDP52 (248Ala) protein in a , and upregulation of activation markers (E, day 2) were investigated. Flow cytometry histograms for E are shown in Supplementary  Figure 6 . Results from studies shown in Figure 2A -E are based on 5 patients with CD with WT PRDM1 expression, 6 patients with CD with PRDM1 Ser354Asn, and 2 patients with CD with PRDM1 Leu450Phe. *P < .05, **P < .01. Mean AE SEM are shown. time-and dose-dependent fashion ( Figure 4D and Supplementary Figure 7) . We constructed an NDP52 protein structure model ( Figure 4C ) in complex with Lys63-linked diubiquitin (PDB ID 3jsv) to visualize the position of the variant in the predicted coiled coil domain (for details, see also Supplementary Notes and Supplementary Figure 8) .
Discussion
The outcomes of the present study highlight the importance of detailed multifaceted analyses to extend genetic insights beyond those derived from GWAS alone. By conducting whole-exome sequencing followed by rare variant analysis, as well as detailed expression and functional studies, we have substantially advanced understanding of a previously defined GWAS locus and have identified a new CD susceptibility gene that further emphasizes the contribution of autophagy and NF-kB pathways to the pathogenesis of CD.
Our findings implicate PRDM1 as the causal gene at the 6q21 CD/UC GWAS locus, combining genetic association with rare coding variants, functional interrogation, and an eQTL effect in 2 disease-relevant tissues. 18, 19 PRDM1 encodes PR domain containing 1, also known as B lymphocyte-induced maturation protein (Blimp-1). It is a zinc finger-containing transcriptional repressor, now known to be a master regulator of terminal B-and T-cell differentiation. 20 The rare Ser354Asn CD risk allele that we identified in PRDM1 led to increased PBL expression of the adhesion molecule L-selectin, which is critical for PBL migration to the sites of intestinal inflammation, and increased CD4 þ and CD8 þ T-cell proliferation, IFN-g secretion, and up-regulation of activation markers on stimulation. Each of these factors may contribute to its pathogenic role. Our observed eQTL signal, correlating expression with genotype for the common PRDM1 SNP rs7746082, has not yet been reported in publicly available data sets. 21 This highlights that genotype expression correlations can be highly tissue specific and must be studied in relevant cell types. 22 Intriguingly, conditional T cell-specific deletion of Prdm1 in mice has been associated with increased numbers of activated effector CD4 þ and CD8 þ T cells, hyperproliferation, increased production of inflammatory cytokines, and the development of spontaneous colitis. 23, 24 In accordance with these observations in mice, we found that PRDM1 expression in the human intestinal mucosa was largely limited to T cells and plasma cells (Supplementary Figure 4) . In addition, PRDM1 was predominantly expressed by effector memory cells within T-cell compartments, characterized by expression of CD45RO ( Figure 1B) . Importantly, ileal biopsy specimens of healthy individuals homozygous for the CD riskassociated allele at rs7746082 showed significantly lower expression of PRDM1 than individuals homozygous for the WT allele ( Figure 1A ). Similar observations were made for purified PBMCs and effector memory T cells ( Figure 1B) . It may therefore be hypothesized that lower PRDM1 expression of rs7746082 risk allele carriers leads to the same proinflammatory effects as in the previously described Prdm1 conditional knockout mice.
We also identified novel genome-wide significant association of the genetic marker rs2303015 with susceptibility to CD. This SNP represents a missense mutation in the gene NDP52 (nuclear dot protein 52 kilodaltons). Initially described as a nuclear protein, 25 NDP52 was later recognized as a cytosolic protein with a crucial role in immunity and as an adaptor for selective autophagy. [26] [27] [28] [29] Besides the detection of ubiquitin-decorated cytosolic bacteria, NDP52 is also essentially involved in an entirely different type of selective autophagy. Inomata et al reported that NDP52 selectively degrades TLR signaling adaptors, leading to attenuated NF-kB activation. 17 In line with this, our data show a role of the missense mutation Val248Ala for differential regulation of NF-kB signaling. Our observation that the risk variant displays an almost complete loss of its ability to restrict NF-kB activation downstream of TLR pathways could be potentially causative for the chronically increased (hyper)activation of NF-kB in patients with CD. 30 Inomata et al showed that proinflammatory gene expression is only suppressed under the condition of A20 silencing and that the coiled coil domain of NDP52 is subjected to polyubiquitination events mediated by the ubiquitin-modifying enzyme A20, 17 which is encoded by positional candidate gene TNFAIP3 within a confirmed CD GWAS locus. 2 The missense mutation described here affects the amino acid Val248, which is located within the coiled coil domain. Because our data additionally argue for an allele-specific effect on NDP52 protein stability ( Figure 4D ), it is tempting to speculate that the same molecular mechanism is causative for both observations (ie, NDP52 degradation and NF-kB inhibition). In summary, we identified NDP52 as an additional autophagy-related risk factor for CD (see pathway details in Supplementary Figure 9) and provide evidence for a functional role of the disease-associated missense mutation in the context of protein stability and differences in its ability to restrict proinflammatory signaling.
The new genetic associations that we have identified emphasize the contribution of risk alleles from across the frequency spectrum to the pathogenesis of CD. Lowfrequency and rare variant associations have been relatively poorly studied to date because they are not generally interrogated by GWAS microarrays and require different study designs and analytic methods. Hence, their contribution to the "missing heritability" of complex disease is largely unknown at present. There is an expectation that many hundreds or thousands of such associations might exist and that the effect sizes might be significantly larger than is typical for common variants. Cumulatively, these might contribute a significant fraction of the current missing heritability and their detection, particularly in the context of large effect sizes, might significantly affect personalized medicine options in the future.
As with the study reported by Nejentsev et al in type 1 diabetes, 31 our detailed sequencing efforts in identifying rare variants in PRDM1 that are associated with CD have helped to pinpoint this as a causal gene at a GWAS locus (or, in our case, immediately adjacent to a GWAS locus). This corroborates the genotype expression analysis described in the preceding text, which suggests that the common IBD-predisposing mechanism is by an effect on transcriptional regulation. Another broader conclusion is that, after a detailed exome sequencing study, we have found only modest evidence that coding variation across the genome makes a major contribution to CD susceptibility. Although our study was underpowered to detect rare variants of small effect size, it would be expected that we would have found much more rare variants if this were a major contribution to missing heritability.
Here we focused sequencing efforts on exomes, but future studies will encompass whole genomes and, as sequencing costs continue to fall dramatically, will study panels comprising thousands of patients with CD. Although our current study suggests that rare coding variation does not contribute greatly to IBD susceptibility, this does not rule out an effect of rare variants in noncoding sequence. Indeed, one of the key lessons from the studies of common variation through GWAS is that such regulatory polymorphisms make a much bigger contribution than do coding variants. Only once whole genome sequencing data have been analyzed will we have a true appreciation of the relative contribution of common versus low-frequency versus rare variants to disease heritability. This will aid understanding of the heterogeneity of genetic effects in CD and the extent to which specific disease strata might benefit from individualized treatment approaches.
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